BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

377 related articles for article (PubMed ID: 28916944)

  • 1. Conflict of Interest and the CREATE-X Trial in the New England Journal of Medicine.
    Ozaki A
    Sci Eng Ethics; 2018 Dec; 24(6):1809-1811. PubMed ID: 28916944
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A call for improved transparency in financial aspects of clinical trials: a case study of the CREATE-X trial in the New England Journal of Medicine.
    Ozaki A; Takita M; Tanimoto T
    Invest New Drugs; 2018 Jun; 36(3):517-522. PubMed ID: 29516231
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Conflict of interest policies and disclosure requirements among European Society of Cardiology National Cardiovascular Journals.
    Alfonso F; Timmis A; Pinto FJ; Ambrosio G; Ector H; Kulakowski P; Vardas P;
    Rev Port Cardiol; 2012 Apr; 31(4):329-36. PubMed ID: 22863109
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Conflicts of interest, authorship, and disclosures in industry-related scientific publications: the tort bar and editorial oversight of medical journals.
    Hirsch LJ
    Mayo Clin Proc; 2009 Sep; 84(9):811-21. PubMed ID: 19720779
    [No Abstract]   [Full Text] [Related]  

  • 5. [Conflict of interest policies and disclosure requirements among European Society of Cardiology National Cardiovascular Journals].
    Alfonso F; Timmis A; Pinto FJ; Ambrosio G; Ector H; Kulakowski P; Vardas P;
    G Ital Cardiol (Rome); 2012 Apr; 13(4):236-43. PubMed ID: 22495640
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Conflict of interest policies and disclosure requirements among European Society of Cardiology National Cardiovascular Journals.
    Alfonso F; Timmis A; Pinto FJ; Ambrosio G; Ector H; Kulakowski P; Vardas P;
    Eur Heart J; 2012 Mar; 33(5):587-94. PubMed ID: 22383145
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Conflict of interest policies and disclosure requirements among European Society of Cardiology national cardiovascular journals.
    Alfonso F; Timmis A; Pinto FJ; Ambrosio G; Ector H; Kulakowski P; Vardas P;
    Hellenic J Cardiol; 2012; 53(3):179-88. PubMed ID: 22653242
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Conflict of interest policies and disclosure requirements among European Society of Cardiology National Cardiovascular Journals.
    Alfonso F; Timmis A; Pinto FJ; Ambrosio G; Ector H; Kulakowski P; Vardas P;
    Heart; 2012 Apr; 98(7):e1-7. PubMed ID: 22422746
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Conflict of interest policies and disclosure requirements among European Society of Cardiology National Cardiovascular Journals.
    Alfonso F; Timmis A; Pinto FJ; Ambrosio G; Ector H; Kulakowski P; Vardas P;
    Arq Bras Cardiol; 2012 Jun; 98(6):471-9. PubMed ID: 22892693
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Conflict of interest policies and disclosure requirements among European Society of Cardiology National Cardiovascular Journals.
    Alfonso F; Timmis A; Pinto FJ; Ambrosio G; Ector H; Kulakowski P; Vardas P;
    Circ J; 2012; 76(7):1542-9. PubMed ID: 22664980
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Editorial ethics questioned.
    Vogel G
    Science; 1997 Feb; 275(5303):1055. PubMed ID: 11644901
    [No Abstract]   [Full Text] [Related]  

  • 12. Drug company links test journal's policy.
    Wadman M
    Nature; 1996 Sep; 383(6595):6. PubMed ID: 8779701
    [No Abstract]   [Full Text] [Related]  

  • 13. Conflict of interest policies and disclosure requirements among European Society of Cardiology National Cardiovascular Journals.
    Alfonso F; Timmis A; Pinto FJ; Ambrosio G; Ector H; Kulakowski P; Vardas P;
    Rev Esp Cardiol (Engl Ed); 2012 May; 65(5):471-8. PubMed ID: 22464101
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A statement on ethics from the HEART group.
    HEART Group
    Catheter Cardiovasc Interv; 2008 May; 71(6):859-61. PubMed ID: 18412086
    [No Abstract]   [Full Text] [Related]  

  • 15. Profits and plagiarism: the case of medical ghostwriting.
    Anekwe TD
    Bioethics; 2010 Jul; 24(6):267-72. PubMed ID: 19222448
    [TBL] [Abstract][Full Text] [Related]  

  • 16. All above board: openness is the only option if science is to maintain its integrity.
    New Sci; 2004 Mar 6-12; 181(2437):3. PubMed ID: 15139348
    [No Abstract]   [Full Text] [Related]  

  • 17. A statement on ethics from the HEART Group.
    HEART Group
    Prog Cardiovasc Dis; 2008; 50(6):475-7. PubMed ID: 18488290
    [No Abstract]   [Full Text] [Related]  

  • 18. Conflict of interest policies and disclosure requirements among European Society of Cardiology National Cardiovascular Journals.
    Alfonso F; Timmis A; Pinto FJ; Ambrosio G; Ector H; Kulakowski P; Vardas P;
    Neth Heart J; 2012 Jun; 20(6):279-87. PubMed ID: 22653813
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Conflicts of interest, authorship, and disclosures in industry-related scientific publications.
    Kelly AR
    Mayo Clin Proc; 2010 Feb; 85(2):200-1. PubMed ID: 20118402
    [No Abstract]   [Full Text] [Related]  

  • 20. Current levels of conflict of interest disclosure in medical publications from Korea.
    Kang BH; Moon JY; Chang Y; Koo YM; Koh Y
    J Korean Med Sci; 2013 Jul; 28(7):978-82. PubMed ID: 23853478
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.